Real-world treatment and outcomes of ALK-positive metastatic non-small cell lung cancer in a Southeast Asian country
Purpose: Anaplastic lymphoma kinase (ALK) inhibitors are associated with good overall survival (OS) for ALK-positive metastatic non-small cell lung cancer (NSCLC). However, these treatments can be unavailable or limited by financial constraints in developing countries. Using data from a nationwide l...
Saved in:
Main Authors: | Poh, Mau Ern, How, Soon Hin, Ho, Gwo Fuang, Pang, Yong Kek, Hasbullah, Harissa H., Tho, Lye Mun, Nor, Ibtisam Muhamad, Lim, Bee Chiu, Ho, Kean Fatt, Thiagarajan, Muthukkumaran, Samsudin, Azlina, Omar, Azza, Ong, Choo Khoon, Soon, Sing Yang, Tan, Justin Yu Kuan, Abidin, Muhammad Adil Zainal |
---|---|
Format: | Article |
Published: |
Dove Medical Press LTD
2023
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/39088/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world treatment and outcomes of ALK-positive metastatic non–small cell lung cancer in a southeast Asian country
by: Poh, Mau Ern, et al.
Published: (2023) -
A case of remarkable response to atezolizumab in ALK-translocated metastatic lung adenocarcinoma
by: Von, Cheong E., et al.
Published: (2021) -
Does dose reduction of afatinib affect treatment outcomes of
patients with EGFR-mutant metastatic non-small cell lung cancer
in real-world clinical practice?
by: Mau, Ern Poh, et al.
Published: (2024) -
Programmed death-ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non-small-cell lung cancer in a resource-limited country
by: How, Soon Hin, et al.
Published: (2022) -
Outcomes of patients with EGFR-mutant
advanced NSCLC in a developing country in
Southeast Asia
by: How, Soon Hin, et al.
Published: (2022)